Acute Treatment of Migraine Using the CEFALY Device
NCT02411513 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2015-12-04
Summary
The purpose of this study is to investigate the efficacy of e-TNS with the Cefaly® device as an acute treatment for a migraine attack. This open clinical trial will study the acute treatment of migraine using the Cefaly® device, prior to development of a sham-controlled trial.
Conditions
Interventions
- DEVICE
-
CEFALY
Sponsors & Collaborators
-
Cefaly Technology
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2015-10-31
Countries
- United States
Study Locations
More Related Trials
-
Occipital Transcutaneous Stimulation in Chronic Migraine
NCT02307071 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of a Wearable Device for Acute Treatment of Migraines
NCT07015125 ·Status: COMPLETED ·Phase: NA
-
Neurostimulation Device for Treatment of Migraine Headache
NCT01630044 ·Status: COMPLETED ·Phase: NA
-
Retrospective Study on the Use of CEFALY® Device During Migraine Attacks
NCT02616978 ·Status: COMPLETED
-
Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine
NCT02037425 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Chronic Migraine With Erenumab Alone or as an Add on Therapy
NCT04152434 ·Status: COMPLETED
-
A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache
NCT02991430 ·Status: TERMINATED ·Phase: NA
-
Adjunctive Treatment of Chronic Migraine Using an Oral Dental Device
NCT04871581 ·Status: COMPLETED ·Phase: NA
-
Repetitive Transcranial Magnetic Stimulation in Treatment and Prophylaxis of Chronic Migraine in Patients With no Prophylactic Treatment for the Last 3 Months
NCT06461767 ·Status: RECRUITING ·Phase: NA
-
The Effect of Galcanezumab-gnlm on Post-Traumatic, Migrainous Headaches
NCT06901518 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura
NCT02614287 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
NCT02797951 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Occipital Nerve Stimulation for Drug Refractory Migraine
NCT00747812 ·Status: TERMINATED ·Phase: PHASE2
-
Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action
NCT04271202 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Efficacy of Intranasal Kinetic Oscillation Stimulation in the Preventive Treatment of Chronic Migraine
NCT03400059 ·Status: COMPLETED ·Phase: NA
-
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
NCT05164172 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of a New Treatment for Migraine Attacks
NCT01880671 ·Status: COMPLETED ·Phase: NA
-
A Study of LY3451838 in Participants With Migraine
NCT04498910 ·Status: COMPLETED ·Phase: PHASE2
-
Exploring Clinical Trial Experiences of Patients With Migraine
NCT05675189 ·Status: NOT_YET_RECRUITING
-
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
NCT03432286 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Occipital Nerve Stimulation for the Treatment of Chronic Migraine Headache.
NCT00200109 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Episodic Migraine With AURICular Neuromodulation
NCT06623188 ·Status: RECRUITING ·Phase: NA
-
Occipital Nerve Stimulation in the Treatment of Migraine
NCT01855672 ·Status: TERMINATED ·Phase: PHASE1
-
Short-term Effectiveness of Transcutaneous Nerve Stimulation in Reducing Migraine Related Pain
NCT02438553 ·Status: COMPLETED ·Phase: NA
-
A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache
NCT01899040 ·Status: COMPLETED ·Phase: NA